Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.76 INR | -1.81% | -1.26% | -24.03% |
05-30 | Lasa Supergenerics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
04-26 | Lasa Supergenerics CFO Steps Down | MT |
Business Summary
Number of employees: 89
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredient Bulk Drugs Products
100.0
%
| 1,371 | 100.0 % | 1,296 | 100.0 % | -5.51% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 1,371 | 100.0 % | 1,296 | 100.0 % | -5.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 43 | 10/03/16 | |
Sunil Sitale
ADM | Chief Administrative Officer | - | - |
Compliance Officer | 37 | 20/03/23 | |
Hitesh Wadhwani
LAW | General Counsel | - | - |
Vijay Bhat
SAM | Sales & Marketing | - | 31/08/10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 43 | 10/03/16 | |
Director/Board Member | 63 | 01/05/17 | |
Director/Board Member | 35 | 01/05/17 | |
Director/Board Member | - | 01/05/17 | |
Director/Board Member | - | 01/05/17 | |
Director/Board Member | - | 11/02/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,101,239 | 18,022,513 ( 35.97 %) | 0 | 35.97 % |
Company contact information
Lasa Supergenerics Ltd.
Office No: 705, Minerva Estate A Wing, 02 Commercial Tower
400080, Mumbai
+
Sector
1st Jan change | Capi. | |
---|---|---|
-12.56% | 79.1B | |
-5.37% | 7.13B | |
+25.38% | 3.58B | |
-6.12% | 2.93B | |
+14.19% | 1.69B | |
-7.71% | 1.19B | |
-32.50% | 1.11B | |
-35.50% | 1.05B | |
-28.56% | 939M |
- Stock Market
- Equities
- LASA Stock
- LASA Stock
- Company Lasa Supergenerics Limited